TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 29426304

Group type: EXPERIMENTAL
Intervention: modified directly observed therapy
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: group treatment
Number of subjects: 150

Group type: COMPARATOR
Intervention: self‐administered individual treatment (control)
Number of subjects: 150
Study: 28156250

Group type: EXPERIMENTAL
Intervention: Deep rTMS with H-coil
Number of subjects: 18

Group type: COMPARATOR
Intervention: Sham group (control)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: rTMS using figure-8 coil
Number of subjects: 18
Study: 25082830

Group type: EXPERIMENTAL
Intervention: Novel nicotine inhaler device (0.45 mg and 0.67 mg)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Nicorette® Inhalator (10 mg)
Number of subjects: 48
Study: 24277401

Group type: EXPERIMENTAL
Intervention: Clean liquid integral protein diet for 3 days before operation without mechanical bowel preparation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Traditional diet and mechanical bowel preparation
Number of subjects: 60
Study: 21515531

Group type: EXPERIMENTAL
Intervention: Statin therapy recommendation for patients with type 1 diabetes
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Statin therapy recommendation for patients with type 2 diabetes
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Statin therapy recommendation for patients with schizophrenia
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Statin therapy recommendation for patients with epilepsy
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Statin therapy recommendation for retired patients
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Statin therapy recommendation for unemployed patients
Number of subjects: 53
Study: 17690160

Group type: EXPERIMENTAL
Intervention: IL-10 plasma concentration in patients with ACS
Number of subjects: 3179

Group type: COMPARATOR
Intervention: IL-10 plasma concentration in healthy controls
Number of subjects: 3179

Group type: EXPERIMENTAL
Intervention: 1170 CC genotype
Number of subjects: 3179
Study: 16990165

Group type: EXPERIMENTAL
Intervention: Participating families with high socioeconomic status and health-related lifestyle factors (non-smoking parents)
Number of subjects: 198

Group type: COMPARATOR
Intervention: Non-participating families
Number of subjects: 198
Study: 14727937

Group type: EXPERIMENTAL
Intervention: roxifiban (DMP754) 2 mg/day
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: roxifiban (DMP754) 2.5 mg/day
Number of subjects: 120

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: roxifiban (DMP754) (all dosages)
Number of subjects: 120
Study: 11225737

Group type: EXPERIMENTAL
Intervention: Nonabusive spanking used to back up milder disciplinary tactics
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Spanking (frequent use)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Alternative disciplinary tactics
Number of subjects: 6
Study: 8630199

Group type: EXPERIMENTAL
Intervention: Mexiletine (450 mg/day)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 1362305

Group type: EXPERIMENTAL
Intervention: Flunitrazepam (Rohypnol tabl. 1 mg), Tramadol (Tramal caps. 50 mg), Metipranolol (Trimepranol tabl. 10 mg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Combination of drugs with Metipranolol
Number of subjects: 8
Study: 31456848

Group type: EXPERIMENTAL
Intervention: Descending light intensities bleaching protocol
Number of subjects: 24

Group type: COMPARATOR
Intervention: High light intensity bleaching protocol
Number of subjects: 24
Study: 29220825

Group type: EXPERIMENTAL
Intervention: Individual nutritional education (Group C)
Number of subjects: 265

Group type: COMPARATOR
Intervention: Doctor's weight loss advice (Group B)
Number of subjects: 265

Group type: COMPARATOR
Intervention: Standard care (Group A)
Number of subjects: 265
Study: 27116464

Group type: EXPERIMENTAL
Intervention: Bazedoxifene 20mg/d
Number of subjects: 39
Study: 24508669

Group type: EXPERIMENTAL
Intervention: 18F-sodium fluoride (18F-NaF)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 18F-fluorodeoxyglucose (18F-FDG)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Histological characterization of the aortic valve
Number of subjects: 30
Study: 22398821

Group type: EXPERIMENTAL
Intervention: 70 μg/kg ephedrine
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg lidocaine
Number of subjects: 120

Group type: COMPARATOR
Intervention: 5 ml NaCl 0.9% (placebo)
Number of subjects: 120
Study: 21909028

Group type: EXPERIMENTAL
Intervention: Sertraline (50-200 mg/day)
Number of subjects: 90

Group type: COMPARATOR
Intervention: T3 (tri-iodothyronine) or matching placebo
Number of subjects: 90
Study: 17604880

Group type: EXPERIMENTAL
Intervention: Extended dosing schedule (0, 10, 13, 32 weeks)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Regular dosing schedule (0, 3, 6, 32 weeks)
Number of subjects: 13
Study: 15642075

Group type: EXPERIMENTAL
Intervention: Orlistat
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Sibutramine
Number of subjects: 115
Study: 12398957

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI)
Number of subjects: 2211
Study: 11775818

Group type: EXPERIMENTAL
Intervention: Preventive studies published in the Chinese Journal of Tuberculosis and Respiratory Diseases
Number of subjects: 394

Group type: EXPERIMENTAL
Intervention: Quality of study design
Number of subjects: 394

Group type: EXPERIMENTAL
Intervention: Improvement of research design and statistical methods
Number of subjects: 394
Study: 7539821

Group type: EXPERIMENTAL
Intervention: Audiovisual product (tape-slide series) explaining a first dental examination
Number of subjects: 28

Group type: COMPARATOR
Intervention: Previous study with developmentally disabled children
Number of subjects: 28
Study: 1967666

Group type: EXPERIMENTAL
Intervention: Mitozantrone 14 mg/m2 intravenously every 3 weeks for 9 weeks
Number of subjects: 132

Group type: COMPARATOR
Intervention: Continue chemotherapy
Number of subjects: 132

Group type: COMPARATOR
Intervention: Stop chemotherapy
Number of subjects: 132
Study: 7358147

Group type: EXPERIMENTAL
Intervention: Oxapadol (MD 720111)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31437008

Group type: EXPERIMENTAL
Intervention: Management by Alternative Care Providers (ACPs) with same-day sleep physician review
Number of subjects: 156

Group type: COMPARATOR
Intervention: Sleep physician management
Number of subjects: 156
Study: 28756764

Group type: EXPERIMENTAL
Intervention: Promoting Early Presentation intervention
Number of subjects: 867

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 867
Study: 27768678

Group type: EXPERIMENTAL
Intervention: Intramedullary nailing (IMN)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Minimally invasive plate osteosynthesis (MIPO)
Number of subjects: 30
Study: 24332432

Group type: EXPERIMENTAL
Intervention: Sayana Press (SP)
Number of subjects: 357

Group type: COMPARATOR
Intervention: DMPA-IM
Number of subjects: 357
Study: 21988932

Group type: EXPERIMENTAL
Intervention: Cryotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham
Number of subjects: 0
Study: 18486133

Group type: EXPERIMENTAL
Intervention: Educational intervention consisting of an educational programme for nurses combined with a nurse specialist's consultation
Number of subjects: 105

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 105
Study: 17502340

Group type: EXPERIMENTAL
Intervention: UK-338,003 (N-[2-(4-amino-6,7-dimethoxy-5-pyridin-2-yl-quinazolin-2-yl)-1,2,3,4-tetrahydro-isoquinolin-5-yl]-methanesulfonamide)
Number of subjects: 0
Study: 15055867

Group type: EXPERIMENTAL
Intervention: Valsartan
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Valsartan (in patients not receiving ACEIs at baseline)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 11845946

Group type: EXPERIMENTAL
Intervention: Adapalene cream 0.1%
Number of subjects: 237

Group type: COMPARATOR
Intervention: Cream vehicle
Number of subjects: 237
Study: 9509440

Group type: EXPERIMENTAL
Intervention: Captopril renal scintigraphy
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Duplex Doppler sonography
Number of subjects: 28
Study: 7511494

Group type: EXPERIMENTAL
Intervention: Modified fluid gelatin (group A)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Hydroxyethyl starch (group B)
Number of subjects: 28
Study: 3245823

Group type: EXPERIMENTAL
Intervention: Prophylactic permanent pacing
Number of subjects: 14

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 14
Study: 30187497

Group type: EXPERIMENTAL
Intervention: Negative motivation (unpleasant electric stimulation for detected lies)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition (no specific motivation)
Number of subjects: 0
Study: 28177908

Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg/d and Ezetimibe 10 mg/d
Number of subjects: 230

Group type: COMPARATOR
Intervention: Atorvastatin 20 mg/d
Number of subjects: 230
Study: 25541389

Group type: EXPERIMENTAL
Intervention: ACDC-rTMS (double cone coil stimulation of the anterior cingulate cortex)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: butterfly-rTMS (conventional rTMS of the left DLPFC)
Number of subjects: 45

Group type: COMPARATOR
Intervention: sham-stimulation
Number of subjects: 45
Study: 23601793

Group type: EXPERIMENTAL
Intervention: Left DLPFC rTMS stimulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 21398040

Group type: EXPERIMENTAL
Intervention: Positive emotional style (PES)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Retrospective measure of positive affect (POMS vigour)
Number of subjects: 40
Study: 19730304

Group type: EXPERIMENTAL
Intervention: 0.2% lidocaine administered through the vacuum-assisted closure tubing into the foam dressing 30 minutes before dressing change
Number of subjects: 70

Group type: COMPARATOR
Intervention: 0.9% saline administered through the vacuum-assisted closure tubing into the foam dressing 30 minutes before dressing change
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: 0.2% lidocaine
Number of subjects: 70

Group type: COMPARATOR
Intervention: 0.9% saline
Number of subjects: 70
Study: 17210817

Group type: EXPERIMENTAL
Intervention: Qualitative measures of medial temporal atrophy (MTA)
Number of subjects: 190

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 190

Group type: COMPARATOR
Intervention: Donepezil hydrochloride or vitamin E
Number of subjects: 190
Study: 15882383

Group type: EXPERIMENTAL
Intervention: Nutrition education intervention
Number of subjects: 74

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 74
Study: 12472837

Group type: EXPERIMENTAL
Intervention: Green tea catechin (slow release local delivery system applied once a week for 8 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (scaled groups without mechanical treatment)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Green tea catechin (slow release local delivery system)
Number of subjects: 0
Study: 9530791

Group type: EXPERIMENTAL
Intervention: 3‐Space Fastrak (Polhemus, Colchester, VT) for measuring spinal position sense
Number of subjects: 20
Study: 7868425

Group type: EXPERIMENTAL
Intervention: 15 days of head-down tilt
Number of subjects: 7
Study: 2475697

Group type: EXPERIMENTAL
Intervention: 40 mg of anipamil
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: 80 mg of anipamil
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: 120 mg of anipamil
Number of subjects: 121

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 121
Study: 781233

Group type: EXPERIMENTAL
Intervention: Fenoprofen (200 mg to 600 mg every six hours)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aspirin (325 mg to 975 mg every six hours)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fenoprofen
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 0
Study: 30724099

Group type: EXPERIMENTAL
Intervention: Vaping without nicotine
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Vaping with nicotine
Number of subjects: 45
Study: 28188151

Group type: EXPERIMENTAL
Intervention: Resuturing
Number of subjects: 34

Group type: COMPARATOR
Intervention: Expectant management
Number of subjects: 34
Study: 26143615

Group type: EXPERIMENTAL
Intervention: Aluminum-adjuvanted trivalent PPrV (50 μg per antigen)
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Aluminum-adjuvanted trivalent PPrV (10 μg)
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Aluminum-adjuvanted trivalent PPrV (25 μg)
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Aluminum-adjuvanted trivalent PPrV (50 μg)
Number of subjects: 280

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 280
Study: 23300160

Group type: EXPERIMENTAL
Intervention: Trivalent inactivated influenza vaccine (TIV) plus 7-valent pneumococcal vaccine (PCV7)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Trivalent inactivated influenza vaccine (TIV) alone
Number of subjects: 0

Group type: COMPARATOR
Intervention: 7-valent pneumococcal vaccine (PCV7) alone
Number of subjects: 0
Study: 21450933

Group type: EXPERIMENTAL
Intervention: Ready-to-use complementary food (RUCF) paste
Number of subjects: 1400

Group type: COMPARATOR
Intervention: Standard corn-soy blend (UNIMIX) porridge
Number of subjects: 1400
Study: 18164470

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Interferential current
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Electrical muscle stimulation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ultrasound
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Thermotherapy
Number of subjects: 0
Study: 16872455

Group type: EXPERIMENTAL
Intervention: Endo Twinn heat plus vibration function
Number of subjects: 64

Group type: COMPARATOR
Intervention: Endo Twinn heat function
Number of subjects: 64
Study: 14719424

Group type: EXPERIMENTAL
Intervention: 0.5% levobupivacaine
Number of subjects: 50

Group type: COMPARATOR
Intervention: 0.5% racemic bupivacaine
Number of subjects: 50
Study: 10207205

Group type: EXPERIMENTAL
Intervention: CO2 inhalation
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Breath holding
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Rebreathing
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Voluntary hyperventilation
Number of subjects: 45
Study: 7821097

Group type: EXPERIMENTAL
Intervention: Eradication of Helicobacter pylori infection; N = 41
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Persistent Helicobacter pylori infection; N = 42
Number of subjects: 83

Group type: COMPARATOR
Intervention: Persistent Helicobacter pylori infection; N = 38
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Eradication of Helicobacter pylori infection; N = 37
Number of subjects: 83
Study: 2295234

Group type: EXPERIMENTAL
Intervention: Pall Ultipor breathing circuit filter (PUBCF)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Heated hot water systems (HHWS)
Number of subjects: 48
Study: 647178

Group type: EXPERIMENTAL
Intervention: 5F/week
Number of subjects: 687

Group type: COMPARATOR
Intervention: 3F/week
Number of subjects: 687
Study: 31487608

Group type: EXPERIMENTAL
Intervention: CT optimal velocity stroking touch
Number of subjects: 0

Group type: COMPARATOR
Intervention: Static touch
Number of subjects: 0
Study: 29096591

Group type: EXPERIMENTAL
Intervention: Flipped classroom instruction (FG, n=48)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Traditional lecture-based instruction (TG, n=47)
Number of subjects: 95
Study: 25112695

Group type: EXPERIMENTAL
Intervention: Telemedicine examination
Number of subjects: 110

Group type: COMPARATOR
Intervention: In-person examination
Number of subjects: 110
Study: 21770863

Group type: EXPERIMENTAL
Intervention: Prototype milk A
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Prototype milk B
Number of subjects: 42

Group type: COMPARATOR
Intervention: Non-supplemented milk
Number of subjects: 42
Study: 19602608

Group type: EXPERIMENTAL
Intervention: Icodextrin (ICO)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Glucose-based solutions (GLU)
Number of subjects: 59
Study: 17879825

Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogens (CEE) at doses of 0.3, 0.625, and 1.25 mg for 3 months each, totaling 9 months of treatment.
Number of subjects: 9
Study: 14693584

Group type: EXPERIMENTAL
Intervention: bupivacaine plus 1 micro g/kg clonidine
Number of subjects: 75

Group type: COMPARATOR
Intervention: bupivacaine alone (control group)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: bupivacaine plus 2 micro g/kg clonidine
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: bupivacaine plus 0.25, 0.5 micro g/kg clonidine
Number of subjects: 75
Study: 12359987

Group type: EXPERIMENTAL
Intervention: Active treatment with nitrendipine (with second- and third-line enalapril and hydrochlorothiazide)
Number of subjects: 610

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 610
Study: 9841599

Group type: EXPERIMENTAL
Intervention: Pravastatin, 40 mg/d
Number of subjects: 1283

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1283
Study: 8721722

Group type: EXPERIMENTAL
Intervention: Nasal polyps with fibrous connective core infiltrated by monocyte-macrophage lineage cells (mixed type)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Nasal polyps with central oedematous connective tissue infiltrated by eosinophils (glandular and oedematous types)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Hypsilateral mucous membranes
Number of subjects: 22
Study: 2654067

Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 38
Study: 474640

Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 31744701

Group type: EXPERIMENTAL
Intervention: Videoconference group meetings (5 sessions, 1.5 hours each)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Remote monitoring only (control group)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Videoconference group meetings
Number of subjects: 112
Study: 31152874

Group type: EXPERIMENTAL
Intervention: AVATAR protocol cryoballoon ablation without assessment of acute PV isolation or overnight hospitalization
Number of subjects: 321

Group type: COMPARATOR
Intervention: Medical therapy with anti-arrhythmic drugs
Number of subjects: 321

Group type: EXPERIMENTAL
Intervention: Conventional cryoballoon ablation with assessment of acute PV isolation
Number of subjects: 321
Study: 27117011

Group type: EXPERIMENTAL
Intervention: Hip brace
Number of subjects: 14

Group type: COMPARATOR
Intervention: Unbraced (control)
Number of subjects: 14
Study: 25319932

Group type: EXPERIMENTAL
Intervention: Poly-L-lactic acid (PLA) filler
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hyaluronic acid (HA) filler
Number of subjects: 0
Study: 24106804

Group type: EXPERIMENTAL
Intervention: Lisdexamfetamine dimesylate (LDX) 30-70 mg/d
Number of subjects: 161

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 161
Study: 21371988

Group type: EXPERIMENTAL
Intervention: Incentive arm offered a £5 Amazon.co.uk gift voucher, a £5 charity donation to Cancer Research UK, or entry in a prize draw for £250 (study 1)
Number of subjects: 3817

Group type: EXPERIMENTAL
Intervention: Incentive arm offered a £10 Amazon.co.uk gift voucher (study 2)
Number of subjects: 3817
Study: 19349547

Group type: EXPERIMENTAL
Intervention: Vitamin D(3) (cholecalciferol) 400 IU and calcium carbonate 1,000 mg daily for 1 year
Number of subjects: 103
Study: 17242259

Group type: EXPERIMENTAL
Intervention: Contrast harmonic sonography-guided radiofrequency ablation
Number of subjects: 40

Group type: COMPARATOR
Intervention: B-mode sonography
Number of subjects: 40
Study: 17064323

Group type: EXPERIMENTAL
Intervention: Activity-based nursing intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control conditions (non-intervention)
Number of subjects: 0
Study: 12560886

Group type: EXPERIMENTAL
Intervention: HA bone cement injected into the vertebral body through curetted pedicles using specially designed needles
Number of subjects: 9

Group type: COMPARATOR
Intervention: Cement injected using 16‐gauge Ostycut biopsy needles via the pedicles
Number of subjects: 9
Study: 10098807

Group type: EXPERIMENTAL
Intervention: In-car enforcement and tutoring system; auditory and visual tutoring messages provided when deviations from normative behaviour were detected.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: In-car enforcement and tutoring system; feedback conditions.
Number of subjects: 0
Study: 8904578

Group type: EXPERIMENTAL
Intervention: Arm below heart position at 2.2 W
Number of subjects: 10

Group type: COMPARATOR
Intervention: Arm above heart position at 2.2 W
Number of subjects: 10

Group type: COMPARATOR
Intervention: Arm above heart position
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Arm below heart position at 1.4 W
Number of subjects: 10
Study: 2007924

Group type: EXPERIMENTAL
Intervention: Casein hydrolysate formula (Alimentum)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Cow milk (10 gm powdered)
Number of subjects: 25
Study: 7064903

Group type: EXPERIMENTAL
Intervention: Human milk
Number of subjects: 28

Group type: COMPARATOR
Intervention: Proprietary formula
Number of subjects: 28
Study: 31825141

Group type: EXPERIMENTAL
Intervention: mFOLFIRI (irinotecan, 5‐fluorouracil and leucovorin)
Number of subjects: 128

Group type: COMPARATOR
Intervention: mFOLFOX7 (oxaliplatin, 5‐fluorouracil and leucovorin)
Number of subjects: 128
Study: 31095602

Group type: EXPERIMENTAL
Intervention: MRCI-K (Korean version of the medication regimen complexity index)
Number of subjects: 335

Group type: COMPARATOR
Intervention: Expert panel evaluation
Number of subjects: 335
Study: 27623161

Group type: EXPERIMENTAL
Intervention: Upper Body Compression Garment (UBCG)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control garment
Number of subjects: 12
Study: 25951857

Group type: EXPERIMENTAL
Intervention: Tofacitinib 2 mg, 5 mg, or 15 mg, twice daily for 12 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo, twice daily for 12 weeks
Number of subjects: 0
Study: 24140677

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI) cohort
Number of subjects: 1800

Group type: COMPARATOR
Intervention: Coronary artery bypass graft (CABG) cohort
Number of subjects: 1800
Study: 21390339

Group type: EXPERIMENTAL
Intervention: Short axis ultrasound guided cannulation
Number of subjects: 99

Group type: COMPARATOR
Intervention: Long axis ultrasound guided cannulation
Number of subjects: 99